C12N 2760/16161
Methods of inactivation or attenuation
C12N2760/16161 (Methods of inactivation or attenuation) appears on 219 US grants and 291 published applications in this corpus.
Search patents in C12N- Granted patents
- 219
- Published applications
- 291
- Assignees
- 136
- Inventors
- 398
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 1 |
| 2002 | 5 | 3 |
| 2003 | 7 | 7 |
| 2004 | 3 | 13 |
| 2005 | 5 | 11 |
| 2006 | 2 | 6 |
| 2007 | 5 | 9 |
| 2008 | 8 | 12 |
| 2009 | 8 | 20 |
| 2010 | 4 | 9 |
| 2011 | 10 | 15 |
| 2012 | 9 | 18 |
| 2013 | 14 | 8 |
| 2014 | 18 | 20 |
| 2015 | 10 | 11 |
| 2016 | 11 | 22 |
| 2017 | 5 | 9 |
| 2018 | 11 | 17 |
| 2019 | 14 | 12 |
| 2020 | 12 | 12 |
| 2021 | 9 | 8 |
| 2022 | 10 | 16 |
| 2023 | 6 | 10 |
| 2024 | 7 | 9 |
| 2025 | 6 | 10 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Hemagglutinin modifications for improved influenza vaccine production10 Mar 2026US 12,569,550 B2St. Jude Children?S Research Hospital
- Viral vaccines and methods of forming the same7 Oct 2025US 12,435,317 B2NDSU Research Foundation
- Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production23 Sep 2025US 12,419,947 B2Najit Technologies, Inc.
- Influenza b virus mutants and uses therefor19 Aug 2025US 12,390,519 B2FluGen, Inc.
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof12 Aug 2025US 12,385,068 B2Boehringer Ingelheim Animal Health USA Inc.
- Influenza b virus mutants and uses therefor10 Sep 2026US 2026/0263586 A1FluGen, Inc.
- Preparation of influenza virus vaccine antigens19 Feb 2026US 2026/0048115 A1Seqirus UK Limited
- Influenza virus vaccines and uses thereof1 Jan 2026US 2026/0001918 A1Icahn School of Medicine at Mount Sinai
- Non-toxic destruction of cancer cells using viral vectored injections20 Nov 2025US 2025/0352628 A1
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
Most cited
By later US patents
- DNA transfection system for the generation of infectious influenza virus91US 6,951,754 B2St. Jude Children?S Research Hospital · 2005
- Method for producing viruses and vaccines in serum-free culture87US 5,753,489 AImmuno Aktiengesellschaft · 1998
- Recombinant tryptophan mutants of influenza86US 6,322,967 B1Aviron · 2001
- Influenza hemagglutinin and neuraminidase variants71US 7,566,458 B2MedImmune, LLC · 2009
- Temperature-sensitive recombinant mutant viruses and a process for producing same48US 3,992,522 AThe United States of America as represented by the Department of Health, Education and Welfare · 1976